

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine catabolic process (GO:0006554) | 6.43810446 |
| 2 | lysine metabolic process (GO:0006553) | 6.43810446 |
| 3 | * drug transmembrane transport (GO:0006855) | 6.39328103 |
| 4 | urate metabolic process (GO:0046415) | 6.01085283 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.92730418 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.92730418 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.89186989 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.89186989 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.82542339 |
| 10 | * drug transport (GO:0015893) | 5.68747861 |
| 11 | cysteine metabolic process (GO:0006534) | 5.66781858 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 5.55437586 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.50062461 |
| 14 | drug catabolic process (GO:0042737) | 5.16263471 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.15326960 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.15326960 |
| 17 | tryptophan catabolic process (GO:0006569) | 5.15326960 |
| 18 | homocysteine metabolic process (GO:0050667) | 5.10259139 |
| 19 | valine metabolic process (GO:0006573) | 5.02898575 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.98812368 |
| 21 | desmosome organization (GO:0002934) | 4.95105006 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.89259762 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.80396256 |
| 24 | kynurenine metabolic process (GO:0070189) | 4.79208065 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 4.79175270 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 4.71702230 |
| 27 | fatty acid beta-oxidation (GO:0006635) | 4.68081161 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.62003519 |
| 29 | exogenous drug catabolic process (GO:0042738) | 4.61515926 |
| 30 | aspartate family amino acid catabolic process (GO:0009068) | 4.55299763 |
| 31 | carnitine shuttle (GO:0006853) | 4.55159641 |
| 32 | regulation of fatty acid oxidation (GO:0046320) | 4.54252150 |
| 33 | response to mercury ion (GO:0046689) | 4.42884395 |
| 34 | epoxygenase P450 pathway (GO:0019373) | 4.40759163 |
| 35 | fatty acid oxidation (GO:0019395) | 4.40024041 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 4.38831138 |
| 37 | skeletal muscle adaptation (GO:0043501) | 4.37774976 |
| 38 | * organic cation transport (GO:0015695) | 4.37443078 |
| 39 | * quaternary ammonium group transport (GO:0015697) | 4.36538278 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.36455011 |
| 41 | bile acid biosynthetic process (GO:0006699) | 4.32989176 |
| 42 | 2-oxoglutarate metabolic process (GO:0006103) | 4.32713480 |
| 43 | lipid oxidation (GO:0034440) | 4.31925741 |
| 44 | macroautophagy (GO:0016236) | 4.24888580 |
| 45 | fatty acid catabolic process (GO:0009062) | 4.21625217 |
| 46 | intestinal epithelial cell development (GO:0060576) | 4.20711612 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.20048529 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 4.17444722 |
| 49 | branched-chain amino acid catabolic process (GO:0009083) | 4.16765261 |
| 50 | phosphate ion transport (GO:0006817) | 4.16594808 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 4.15799725 |
| 52 | acetyl-CoA metabolic process (GO:0006084) | 4.15543136 |
| 53 | striated muscle atrophy (GO:0014891) | 4.14346308 |
| 54 | carnitine metabolic process (GO:0009437) | 4.13277949 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.11111586 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 4.09478795 |
| 57 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.05612023 |
| 58 | monocarboxylic acid catabolic process (GO:0072329) | 4.01555293 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 3.99978874 |
| 60 | positive regulation of fatty acid oxidation (GO:0046321) | 3.99278669 |
| 61 | serine family amino acid metabolic process (GO:0009069) | 3.99044435 |
| 62 | vitamin transmembrane transport (GO:0035461) | 3.96984340 |
| 63 | urea cycle (GO:0000050) | 3.94964087 |
| 64 | urea metabolic process (GO:0019627) | 3.94964087 |
| 65 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.94483210 |
| 66 | * carnitine transmembrane transport (GO:1902603) | 3.93601117 |
| 67 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.88027756 |
| 68 | phosphate ion transmembrane transport (GO:0035435) | 3.86946531 |
| 69 | drug metabolic process (GO:0017144) | 3.85147645 |
| 70 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.84062563 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.83261841 |
| 72 | labyrinthine layer development (GO:0060711) | 3.83242378 |
| 73 | organic acid catabolic process (GO:0016054) | 3.82790436 |
| 74 | carboxylic acid catabolic process (GO:0046395) | 3.82790436 |
| 75 | glutamate metabolic process (GO:0006536) | 3.81984606 |
| 76 | NADH metabolic process (GO:0006734) | 3.81658599 |
| 77 | bile acid metabolic process (GO:0008206) | 3.75013637 |
| 78 | cellular glucuronidation (GO:0052695) | 3.73718376 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 3.68424340 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 3.67007697 |
| 81 | intestinal absorption (GO:0050892) | 3.66915608 |
| 82 | fructose metabolic process (GO:0006000) | 3.65485739 |
| 83 | ethanol oxidation (GO:0006069) | 3.64749686 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.62636918 |
| 85 | ketone body metabolic process (GO:1902224) | 3.62253343 |
| 86 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62174835 |
| 87 | 4-hydroxyproline metabolic process (GO:0019471) | 3.61324693 |
| 88 | flavonoid metabolic process (GO:0009812) | 3.58651412 |
| 89 | biotin metabolic process (GO:0006768) | 3.58381020 |
| 90 | * amino-acid betaine transport (GO:0015838) | 3.56478255 |
| 91 | * carnitine transport (GO:0015879) | 3.56478255 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.55924323 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.55924323 |
| 94 | iron ion import (GO:0097286) | 3.55209014 |
| 95 | tyrosine metabolic process (GO:0006570) | 3.55200553 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.53449595 |
| 97 | amine catabolic process (GO:0009310) | 3.53449595 |
| 98 | muscle atrophy (GO:0014889) | 3.53289769 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.53116283 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.49890121 |
| 101 | negative regulation of sterol transport (GO:0032372) | 3.49174364 |
| 102 | negative regulation of cholesterol transport (GO:0032375) | 3.49174364 |
| 103 | protein hydroxylation (GO:0018126) | 3.48584998 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.47364078 |
| 105 | vitamin D metabolic process (GO:0042359) | 3.40042810 |
| 106 | xenobiotic catabolic process (GO:0042178) | 3.38947692 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.37784803 |
| 108 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36971549 |
| 109 | heme transport (GO:0015886) | 3.30928671 |
| 110 | protein carboxylation (GO:0018214) | 3.29916098 |
| 111 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.29916098 |
| 112 | response to nitrosative stress (GO:0051409) | 3.27920405 |
| 113 | modified amino acid transport (GO:0072337) | 3.26429189 |
| 114 | small molecule catabolic process (GO:0044282) | 3.25921427 |
| 115 | fatty acid transmembrane transport (GO:1902001) | 3.25425682 |
| 116 | complement activation, alternative pathway (GO:0006957) | 3.24828212 |
| 117 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.24372631 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 3.20501615 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.19758633 |
| 120 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.19050523 |
| 121 | response to nitric oxide (GO:0071731) | 3.18423437 |
| 122 | triglyceride homeostasis (GO:0070328) | 3.17722648 |
| 123 | acylglycerol homeostasis (GO:0055090) | 3.17722648 |
| 124 | regulation of protein activation cascade (GO:2000257) | 3.17033542 |
| 125 | regulation of cholesterol metabolic process (GO:0090181) | 3.11271770 |
| 126 | peptidyl-proline hydroxylation (GO:0019511) | 3.05854204 |
| 127 | diterpenoid biosynthetic process (GO:0016102) | 3.03745869 |
| 128 | regulation of guanylate cyclase activity (GO:0031282) | 3.02463515 |
| 129 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.97598407 |
| 130 | angiotensin maturation (GO:0002003) | 2.82423000 |
| 131 | multicellular organismal water homeostasis (GO:0050891) | 2.81511770 |
| 132 | phenylpropanoid metabolic process (GO:0009698) | 2.79607727 |
| 133 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.75997477 |
| 134 | regulation of keratinocyte differentiation (GO:0045616) | 2.75436947 |
| 135 | auditory receptor cell differentiation (GO:0042491) | 2.74668345 |
| 136 | hemidesmosome assembly (GO:0031581) | 2.74522911 |
| 137 | regulation of water loss via skin (GO:0033561) | 2.71406548 |
| 138 | excretion (GO:0007588) | 2.69096950 |
| 139 | bile acid and bile salt transport (GO:0015721) | 2.66226740 |
| 140 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.66104887 |
| 141 | negative regulation of fatty acid transport (GO:2000192) | 2.64630936 |
| 142 | sulfate transport (GO:0008272) | 2.59815128 |
| 143 | creatine metabolic process (GO:0006600) | 2.59020841 |
| 144 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.58652463 |
| 145 | sulfur compound transport (GO:0072348) | 2.57770537 |
| 146 | keratinocyte development (GO:0003334) | 2.57641688 |
| 147 | regulation of skeletal muscle contraction (GO:0014819) | 2.56182938 |
| 148 | water homeostasis (GO:0030104) | 2.55272217 |
| 149 | steroid hormone mediated signaling pathway (GO:0043401) | 2.52135548 |
| 150 | digestion (GO:0007586) | 2.51475010 |
| 151 | relaxation of cardiac muscle (GO:0055119) | 2.49789409 |
| 152 | sulfate transmembrane transport (GO:1902358) | 2.48784281 |
| 153 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.46761561 |
| 154 | coenzyme catabolic process (GO:0009109) | 2.46751368 |
| 155 | phenol-containing compound catabolic process (GO:0019336) | 2.46525862 |
| 156 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.45364269 |
| 157 | response to growth hormone (GO:0060416) | 2.45084709 |
| 158 | positive regulation of lipid catabolic process (GO:0050996) | 2.42059555 |
| 159 | motile cilium assembly (GO:0044458) | 2.40009144 |
| 160 | nitric oxide biosynthetic process (GO:0006809) | 2.39020334 |
| 161 | intracellular lipid transport (GO:0032365) | 2.38301896 |
| 162 | sarcomere organization (GO:0045214) | 2.36322823 |
| 163 | sphingomyelin metabolic process (GO:0006684) | 2.35419169 |
| 164 | ethanol metabolic process (GO:0006067) | 2.34908689 |
| 165 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.34873145 |
| 166 | early endosome to late endosome transport (GO:0045022) | 2.33875906 |
| 167 | tight junction assembly (GO:0070830) | 2.31770271 |
| 168 | long-chain fatty acid transport (GO:0015909) | 2.30403061 |
| 169 | regulation of hippo signaling (GO:0035330) | 2.29536342 |
| 170 | cellular carbohydrate catabolic process (GO:0044275) | 2.29286460 |
| 171 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.28371373 |
| 172 | cornea development in camera-type eye (GO:0061303) | 2.28186716 |
| 173 | establishment of skin barrier (GO:0061436) | 2.27860604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.10678847 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.81769911 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.05219802 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.92802484 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.31588402 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.48941386 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.90897158 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.25432306 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22190106 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.90286986 |
| 11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.80390808 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.71319649 |
| 13 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.69878393 |
| 14 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.36359414 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16876774 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.15248412 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.03318486 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.00832955 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98837518 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.96730242 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94522115 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89367007 |
| 23 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.86031689 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.85943913 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.79176147 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78582650 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78340951 |
| 28 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.73891388 |
| 29 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.73891388 |
| 30 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.67867695 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63961826 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62931190 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62364831 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62046570 |
| 35 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.58201076 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53790556 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52644114 |
| 38 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.49344317 |
| 39 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.48833854 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47966434 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.45376376 |
| 42 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.44473530 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40798195 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38203543 |
| 45 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37690887 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35237131 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.34284332 |
| 48 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.31501045 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30546555 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26816108 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23688415 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23319345 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21932768 |
| 54 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19794960 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19372293 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17387642 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15995437 |
| 58 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.15114704 |
| 59 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.12584413 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10048478 |
| 61 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07598707 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05048732 |
| 63 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.04580980 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02976902 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02068187 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00432760 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98516748 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97104559 |
| 69 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96837425 |
| 70 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96250440 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96180380 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95972207 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95303077 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95129427 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94630907 |
| 76 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.93731643 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93595991 |
| 78 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.93003635 |
| 79 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91868419 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91331042 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90980707 |
| 82 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90824707 |
| 83 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90824707 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90013829 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90001265 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89985803 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87826334 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87823118 |
| 89 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85788668 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83171480 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82922638 |
| 92 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.82428158 |
| 93 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82109850 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81476857 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81013356 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80806116 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80776536 |
| 98 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.80102539 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80014085 |
| 100 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.79599672 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79091148 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79026061 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78949665 |
| 104 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.78621614 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78095351 |
| 106 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76227896 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75910053 |
| 108 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74211689 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.74138888 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73023367 |
| 111 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72991737 |
| 112 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.72599008 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72304915 |
| 114 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72018829 |
| 115 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.71504799 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71318047 |
| 117 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.71304801 |
| 118 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69642012 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68883583 |
| 120 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.68700024 |
| 121 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68055889 |
| 122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.66438974 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63707347 |
| 124 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.62627010 |
| 125 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62521073 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60998740 |
| 127 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60734228 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59742260 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59742260 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59665558 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.59527262 |
| 132 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59299841 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.59142199 |
| 134 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58246933 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58093393 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58062338 |
| 137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.57653835 |
| 138 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.57535812 |
| 139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.57101524 |
| 140 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56890615 |
| 141 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56231120 |
| 142 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.55866226 |
| 143 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.54837686 |
| 144 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.54791784 |
| 145 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.53415517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.60073822 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.96088369 |
| 3 | MP0005365_abnormal_bile_salt | 4.62695038 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.56194408 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.45999049 |
| 6 | * MP0005332_abnormal_amino_acid | 3.65425148 |
| 7 | MP0003252_abnormal_bile_duct | 3.42766663 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.38141071 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 3.27095079 |
| 10 | MP0003195_calcinosis | 3.26767393 |
| 11 | MP0000383_abnormal_hair_follicle | 3.06891324 |
| 12 | MP0010678_abnormal_skin_adnexa | 2.88713077 |
| 13 | MP0004043_abnormal_pH_regulation | 2.86470133 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.82783089 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.74376478 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.63958498 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.62327882 |
| 18 | * MP0009643_abnormal_urine_homeostasis | 2.59853739 |
| 19 | MP0009840_abnormal_foam_cell | 2.52635919 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.36748229 |
| 21 | MP0004484_altered_response_of | 2.36685687 |
| 22 | MP0004233_abnormal_muscle_weight | 2.34058188 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.09089768 |
| 24 | MP0001756_abnormal_urination | 1.89372241 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.88073617 |
| 26 | MP0005670_abnormal_white_adipose | 1.87251497 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 1.83633630 |
| 28 | MP0001765_abnormal_ion_homeostasis | 1.83032434 |
| 29 | MP0000427_abnormal_hair_cycle | 1.78951772 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.78730242 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.78727795 |
| 32 | MP0001873_stomach_inflammation | 1.78303745 |
| 33 | * MP0000609_abnormal_liver_physiology | 1.73950463 |
| 34 | * MP0002136_abnormal_kidney_physiology | 1.71201082 |
| 35 | MP0000003_abnormal_adipose_tissue | 1.69794848 |
| 36 | MP0005083_abnormal_biliary_tract | 1.67115368 |
| 37 | MP0003186_abnormal_redox_activity | 1.66469246 |
| 38 | MP0001664_abnormal_digestion | 1.54337774 |
| 39 | MP0002098_abnormal_vibrissa_morphology | 1.51334789 |
| 40 | MP0005409_darkened_coat_color | 1.50265033 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.49864415 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.46323322 |
| 43 | MP0001764_abnormal_homeostasis | 1.45708657 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.40193042 |
| 45 | MP0005451_abnormal_body_composition | 1.39712485 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.39048691 |
| 47 | MP0002009_preneoplasia | 1.39027401 |
| 48 | MP0000579_abnormal_nail_morphology | 1.34595243 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.34301626 |
| 50 | MP0003879_abnormal_hair_cell | 1.33643023 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.33315799 |
| 52 | MP0000749_muscle_degeneration | 1.31729647 |
| 53 | MP0006138_congestive_heart_failure | 1.30579746 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.30508742 |
| 55 | MP0000747_muscle_weakness | 1.27269547 |
| 56 | MP0004087_abnormal_muscle_fiber | 1.25731426 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.18063765 |
| 58 | MP0002269_muscular_atrophy | 1.17017436 |
| 59 | MP0004130_abnormal_muscle_cell | 1.15870234 |
| 60 | MP0004381_abnormal_hair_follicle | 1.15252596 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.15227060 |
| 62 | MP0003878_abnormal_ear_physiology | 1.13794222 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.13794222 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.12290876 |
| 65 | MP0000462_abnormal_digestive_system | 1.10275248 |
| 66 | MP0010630_abnormal_cardiac_muscle | 1.08003768 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.07800515 |
| 68 | MP0002249_abnormal_larynx_morphology | 1.07316222 |
| 69 | MP0002254_reproductive_system_inflammat | 1.05443547 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.04153711 |
| 71 | MP0002160_abnormal_reproductive_system | 1.03586430 |
| 72 | MP0000467_abnormal_esophagus_morphology | 1.02179005 |
| 73 | MP0000538_abnormal_urinary_bladder | 1.01042107 |
| 74 | * MP0000598_abnormal_liver_morphology | 0.99672493 |
| 75 | MP0001958_emphysema | 0.99305949 |
| 76 | MP0001661_extended_life_span | 0.99237387 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.98641103 |
| 78 | MP0003724_increased_susceptibility_to | 0.97077641 |
| 79 | MP0004084_abnormal_cardiac_muscle | 0.95596948 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 0.95393931 |
| 81 | MP0000377_abnormal_hair_follicle | 0.95363786 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.95035578 |
| 83 | MP0005501_abnormal_skin_physiology | 0.94868907 |
| 84 | MP0002132_abnormal_respiratory_system | 0.94186350 |
| 85 | MP0003866_abnormal_defecation | 0.94096207 |
| 86 | MP0004147_increased_porphyrin_level | 0.93019043 |
| 87 | MP0009764_decreased_sensitivity_to | 0.91038516 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.89675984 |
| 89 | MP0002971_abnormal_brown_adipose | 0.89207912 |
| 90 | MP0000627_abnormal_mammary_gland | 0.89182660 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.88254333 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.88245002 |
| 93 | MP0000604_amyloidosis | 0.88181007 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.87701790 |
| 95 | MP0003045_fibrosis | 0.87348827 |
| 96 | MP0008469_abnormal_protein_level | 0.87191262 |
| 97 | MP0003690_abnormal_glial_cell | 0.86333093 |
| 98 | MP0005535_abnormal_body_temperature | 0.85906301 |
| 99 | * MP0009642_abnormal_blood_homeostasis | 0.85618326 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.85579249 |
| 101 | MP0003868_abnormal_feces_composition | 0.85371746 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.85072622 |
| 103 | MP0005620_abnormal_muscle_contractility | 0.84938073 |
| 104 | MP0005448_abnormal_energy_balance | 0.84290262 |
| 105 | MP0004264_abnormal_extraembryonic_tissu | 0.83586924 |
| 106 | MP0002168_other_aberrant_phenotype | 0.81722907 |
| 107 | MP0002928_abnormal_bile_duct | 0.81690050 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.81579102 |
| 109 | MP0000477_abnormal_intestine_morphology | 0.77348160 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.77046641 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.76470577 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.76171879 |
| 113 | MP0000751_myopathy | 0.75757933 |
| 114 | MP0002972_abnormal_cardiac_muscle | 0.73352993 |
| 115 | MP0009763_increased_sensitivity_to | 0.73268504 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.72164100 |
| 117 | MP0002127_abnormal_cardiovascular_syste | 0.71744733 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 0.71081087 |
| 119 | MP0005385_cardiovascular_system_phenoty | 0.71081087 |
| 120 | MP0002135_abnormal_kidney_morphology | 0.68947515 |
| 121 | * MP0002078_abnormal_glucose_homeostasis | 0.68301002 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.67351780 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.66436734 |
| 124 | MP0005647_abnormal_sex_gland | 0.64832173 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.62526982 |
| 126 | MP0005334_abnormal_fat_pad | 0.62468282 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.62422971 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.57729230 |
| 129 | MP0005165_increased_susceptibility_to | 0.54248076 |
| 130 | MP0003075_altered_response_to | 0.53646996 |
| 131 | MP0003646_muscle_fatigue | 0.52465816 |
| 132 | MP0002796_impaired_skin_barrier | 0.52130871 |
| 133 | MP0009697_abnormal_copulation | 0.49939178 |
| 134 | MP0005408_hypopigmentation | 0.49429872 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.49409978 |
| 136 | MP0005395_other_phenotype | 0.49003201 |
| 137 | MP0003329_amyloid_beta_deposits | 0.48835144 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.48756557 |
| 139 | MP0005166_decreased_susceptibility_to | 0.48632093 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.47858201 |
| 141 | MP0005330_cardiomyopathy | 0.47533407 |
| 142 | MP0004885_abnormal_endolymph | 0.44679929 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.43511205 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.42560775 |
| 145 | MP0005266_abnormal_metabolism | 0.42533812 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.42256774 |
| 147 | MP0003953_abnormal_hormone_level | 0.41423179 |
| 148 | MP0006082_CNS_inflammation | 0.40381997 |
| 149 | MP0009115_abnormal_fat_cell | 0.40135274 |
| 150 | MP0002166_altered_tumor_susceptibility | 0.38453921 |
| 151 | MP0008873_increased_physiological_sensi | 0.37290464 |
| 152 | MP0008872_abnormal_physiological_respon | 0.34937722 |
| 153 | MP0000249_abnormal_blood_vessel | 0.34571221 |
| 154 | MP0004185_abnormal_adipocyte_glucose | 0.34475655 |
| 155 | MP0005464_abnormal_platelet_physiology | 0.34271640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.43762337 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.34303134 |
| 3 | Gout (HP:0001997) | 5.19302965 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.18524212 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.81992441 |
| 6 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.76163249 |
| 7 | Abnormality of glycine metabolism (HP:0010895) | 4.76163249 |
| 8 | Increased circulating renin level (HP:0000848) | 4.54817141 |
| 9 | Hypokalemic alkalosis (HP:0001949) | 4.50249894 |
| 10 | Xanthomatosis (HP:0000991) | 4.47913679 |
| 11 | Proximal tubulopathy (HP:0000114) | 4.44047242 |
| 12 | Ketosis (HP:0001946) | 4.35172487 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.28721953 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 4.20240481 |
| 15 | Metabolic alkalosis (HP:0200114) | 4.15354854 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 4.14462322 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 4.13207110 |
| 18 | Ketoacidosis (HP:0001993) | 4.10670672 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.04817150 |
| 20 | * Hyperammonemia (HP:0001987) | 4.04660911 |
| 21 | Increased purine levels (HP:0004368) | 3.87997532 |
| 22 | Hyperuricemia (HP:0002149) | 3.87997532 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.82206676 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.78096628 |
| 25 | Deep venous thrombosis (HP:0002625) | 3.73030651 |
| 26 | Exercise-induced myalgia (HP:0003738) | 3.70935611 |
| 27 | Hypomagnesemia (HP:0002917) | 3.69051760 |
| 28 | Alkalosis (HP:0001948) | 3.66787440 |
| 29 | Abnormality of chloride homeostasis (HP:0011422) | 3.65830682 |
| 30 | Abnormal urine output (HP:0012590) | 3.65762147 |
| 31 | Hyperglycinemia (HP:0002154) | 3.65711530 |
| 32 | Polyuria (HP:0000103) | 3.62004491 |
| 33 | Hyperkalemia (HP:0002153) | 3.60101309 |
| 34 | Decreased circulating renin level (HP:0003351) | 3.51341659 |
| 35 | Bundle branch block (HP:0011710) | 3.49888866 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.48165067 |
| 37 | Abnormality of renal excretion (HP:0011036) | 3.47024879 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 3.36683297 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.35443740 |
| 40 | Hydroxyprolinuria (HP:0003080) | 3.31816866 |
| 41 | Abnormality of proline metabolism (HP:0010907) | 3.31816866 |
| 42 | Hypoglycemic coma (HP:0001325) | 3.31039390 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 3.28693824 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.28693824 |
| 45 | Hypobetalipoproteinemia (HP:0003563) | 3.23622076 |
| 46 | Lip pit (HP:0100267) | 3.23464868 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 3.23440212 |
| 48 | Abnormality of urine glucose concentration (HP:0011016) | 3.23328557 |
| 49 | Glycosuria (HP:0003076) | 3.23328557 |
| 50 | Muscle fiber inclusion bodies (HP:0100299) | 3.10780573 |
| 51 | Abnormality of magnesium homeostasis (HP:0004921) | 3.10217489 |
| 52 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.09667365 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.02732803 |
| 54 | Delayed CNS myelination (HP:0002188) | 3.01632011 |
| 55 | Vascular calcification (HP:0004934) | 3.00309251 |
| 56 | Metabolic acidosis (HP:0001942) | 3.00307688 |
| 57 | Dysmetric saccades (HP:0000641) | 2.94298809 |
| 58 | Flat acetabular roof (HP:0003180) | 2.88459641 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.83558710 |
| 60 | Abnormality of potassium homeostasis (HP:0011042) | 2.83376253 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.81590701 |
| 62 | Abnormal drinking behavior (HP:0030082) | 2.78757624 |
| 63 | Polydipsia (HP:0001959) | 2.78757624 |
| 64 | Renal salt wasting (HP:0000127) | 2.74375082 |
| 65 | Hyperaldosteronism (HP:0000859) | 2.70827896 |
| 66 | Abnormality of renin-angiotensin system (HP:0000847) | 2.70807947 |
| 67 | Malnutrition (HP:0004395) | 2.70745308 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.68797320 |
| 69 | Complement deficiency (HP:0004431) | 2.68386888 |
| 70 | Epidermoid cyst (HP:0200040) | 2.67138583 |
| 71 | Fat malabsorption (HP:0002630) | 2.66927451 |
| 72 | Tetany (HP:0001281) | 2.62458545 |
| 73 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.62158812 |
| 74 | Hyponatremia (HP:0002902) | 2.60762272 |
| 75 | * Lethargy (HP:0001254) | 2.60531316 |
| 76 | Myoglobinuria (HP:0002913) | 2.59602795 |
| 77 | Prolonged partial thromboplastin time (HP:0003645) | 2.58864321 |
| 78 | * Vomiting (HP:0002013) | 2.53382389 |
| 79 | Septate vagina (HP:0001153) | 2.52208401 |
| 80 | Ileus (HP:0002595) | 2.50884127 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.47630790 |
| 82 | Onycholysis (HP:0001806) | 2.46585795 |
| 83 | Nephrolithiasis (HP:0000787) | 2.42540820 |
| 84 | Renal tubular acidosis (HP:0001947) | 2.41702111 |
| 85 | Syncope (HP:0001279) | 2.41526265 |
| 86 | Abdominal distention (HP:0003270) | 2.40479117 |
| 87 | Rhabdomyolysis (HP:0003201) | 2.37929227 |
| 88 | Hyperphosphaturia (HP:0003109) | 2.37350097 |
| 89 | Nemaline bodies (HP:0003798) | 2.34674663 |
| 90 | Rickets (HP:0002748) | 2.32966572 |
| 91 | Joint hemorrhage (HP:0005261) | 2.29679213 |
| 92 | Ventricular tachycardia (HP:0004756) | 2.28676440 |
| 93 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27700020 |
| 94 | Hepatocellular carcinoma (HP:0001402) | 2.27514876 |
| 95 | Cerebellar dysplasia (HP:0007033) | 2.26965948 |
| 96 | Myopathic facies (HP:0002058) | 2.26550581 |
| 97 | Nausea (HP:0002018) | 2.26462382 |
| 98 | Abnormality of alanine metabolism (HP:0010916) | 2.25215895 |
| 99 | Hyperalaninemia (HP:0003348) | 2.25215895 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.25215895 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 2.24326048 |
| 102 | Irritability (HP:0000737) | 2.24137776 |
| 103 | Short nail (HP:0001799) | 2.21810375 |
| 104 | Pancreatitis (HP:0001733) | 2.18659695 |
| 105 | Hypercholesterolemia (HP:0003124) | 2.18509971 |
| 106 | Germ cell neoplasia (HP:0100728) | 2.18152325 |
| 107 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.18080981 |
| 108 | Hyperventilation (HP:0002883) | 2.15737120 |
| 109 | Abnormal urine phosphate concentration (HP:0012599) | 2.14910585 |
| 110 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13619993 |
| 111 | Enlarged kidneys (HP:0000105) | 2.13413976 |
| 112 | Adrenal overactivity (HP:0002717) | 2.12862545 |
| 113 | Heart block (HP:0012722) | 2.12636833 |
| 114 | Abnormality of the calf musculature (HP:0001430) | 2.11321313 |
| 115 | Hyperbilirubinemia (HP:0002904) | 2.10526867 |
| 116 | Vacuolated lymphocytes (HP:0001922) | 2.10223551 |
| 117 | Pigmentary retinal degeneration (HP:0001146) | 2.10070646 |
| 118 | Pili torti (HP:0003777) | 2.08477350 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.08383725 |
| 120 | Abnormal atrioventricular conduction (HP:0005150) | 2.08174032 |
| 121 | Spastic diplegia (HP:0001264) | 2.07546312 |
| 122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06945338 |
| 123 | Thin bony cortex (HP:0002753) | 2.06531636 |
| 124 | EMG: myopathic abnormalities (HP:0003458) | 2.06270385 |
| 125 | Focal segmental glomerulosclerosis (HP:0000097) | 2.05419138 |
| 126 | Bulbar palsy (HP:0001283) | 2.04804312 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 2.04540534 |
| 128 | Palpitations (HP:0001962) | 2.03936849 |
| 129 | Esophageal varix (HP:0002040) | 2.02110433 |
| 130 | Popliteal pterygium (HP:0009756) | 2.01293984 |
| 131 | EMG: neuropathic changes (HP:0003445) | 2.01289120 |
| 132 | Hypophosphatemia (HP:0002148) | 2.00377617 |
| 133 | Methylmalonic aciduria (HP:0012120) | 1.99966917 |
| 134 | Hypokalemia (HP:0002900) | 1.99861826 |
| 135 | Abnormality of vitamin metabolism (HP:0100508) | 1.99021322 |
| 136 | Hypercalciuria (HP:0002150) | 1.98398482 |
| 137 | Calf muscle hypertrophy (HP:0008981) | 1.97326185 |
| 138 | Myocardial infarction (HP:0001658) | 1.97140749 |
| 139 | Hypoplasia of dental enamel (HP:0006297) | 1.97002891 |
| 140 | Cerebral edema (HP:0002181) | 1.95794135 |
| 141 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.94686461 |
| 142 | Abnormality of the nasal septum (HP:0000419) | 1.94457886 |
| 143 | Progressive muscle weakness (HP:0003323) | 1.93936415 |
| 144 | Steatorrhea (HP:0002570) | 1.93396501 |
| 145 | Sparse lateral eyebrow (HP:0005338) | 1.92934491 |
| 146 | Clumsiness (HP:0002312) | 1.91758631 |
| 147 | Late onset (HP:0003584) | 1.91709170 |
| 148 | Abnormal hair laboratory examination (HP:0003328) | 1.90582215 |
| 149 | Widely patent fontanelles and sutures (HP:0004492) | 1.90167474 |
| 150 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90106406 |
| 151 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88506379 |
| 152 | Amelogenesis imperfecta (HP:0000705) | 1.86858000 |
| 153 | Dehydration (HP:0001944) | 1.85564998 |
| 154 | Abnormal glucose tolerance (HP:0001952) | 1.85120151 |
| 155 | Abnormality of sodium homeostasis (HP:0010931) | 1.84502078 |
| 156 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84136975 |
| 157 | Abnormality of vitamin B metabolism (HP:0004340) | 1.83765647 |
| 158 | Neonatal onset (HP:0003623) | 1.81670239 |
| 159 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.80074994 |
| 160 | Muscle fiber splitting (HP:0003555) | 1.79411981 |
| 161 | Atrioventricular block (HP:0001678) | 1.78444539 |
| 162 | Ventricular arrhythmia (HP:0004308) | 1.76560896 |
| 163 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.75832504 |
| 164 | Villous atrophy (HP:0011473) | 1.75832504 |
| 165 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73592566 |
| 166 | Hypotension (HP:0002615) | 1.72182733 |
| 167 | Tubular atrophy (HP:0000092) | 1.70105434 |
| 168 | Sudden death (HP:0001699) | 1.69884416 |
| 169 | Distal lower limb muscle weakness (HP:0009053) | 1.69480033 |
| 170 | Potter facies (HP:0002009) | 1.69412432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.51777435 |
| 2 | BCKDK | 4.93694956 |
| 3 | OXSR1 | 4.42088874 |
| 4 | WNK3 | 4.28878387 |
| 5 | FGFR4 | 2.98086242 |
| 6 | STK39 | 2.95613532 |
| 7 | ACVR1B | 2.70433293 |
| 8 | MAPKAPK3 | 2.56606482 |
| 9 | PBK | 2.44637388 |
| 10 | FRK | 2.43611283 |
| 11 | ERN1 | 2.43400408 |
| 12 | EEF2K | 2.37932578 |
| 13 | AKT3 | 2.36866299 |
| 14 | PDK3 | 2.28456457 |
| 15 | PDK4 | 2.28456457 |
| 16 | TRIB3 | 2.26336002 |
| 17 | OBSCN | 2.19004795 |
| 18 | SIK1 | 2.03349244 |
| 19 | EPHB1 | 1.95609928 |
| 20 | MST1R | 1.83712856 |
| 21 | PKN2 | 1.82665165 |
| 22 | TRPM7 | 1.77618564 |
| 23 | PDK2 | 1.74698744 |
| 24 | RPS6KB2 | 1.70216601 |
| 25 | RIPK1 | 1.69992309 |
| 26 | FGFR2 | 1.66377912 |
| 27 | CDK12 | 1.63044492 |
| 28 | PHKG2 | 1.53411305 |
| 29 | PHKG1 | 1.53411305 |
| 30 | MAP3K6 | 1.48287466 |
| 31 | NEK6 | 1.40184392 |
| 32 | EPHA2 | 1.34851711 |
| 33 | TYK2 | 1.32289474 |
| 34 | MUSK | 1.32032138 |
| 35 | KDR | 1.28461807 |
| 36 | TIE1 | 1.28456922 |
| 37 | PTK6 | 1.27654944 |
| 38 | TGFBR2 | 1.26057311 |
| 39 | MAP3K3 | 1.24981121 |
| 40 | FLT3 | 1.24922716 |
| 41 | MAP2K3 | 1.22749476 |
| 42 | RET | 1.20787518 |
| 43 | INSRR | 1.20052696 |
| 44 | STK38L | 1.18290833 |
| 45 | ICK | 1.17346541 |
| 46 | SGK494 | 1.15770053 |
| 47 | SGK223 | 1.15770053 |
| 48 | GRK6 | 1.11553995 |
| 49 | MAP2K1 | 1.09547743 |
| 50 | TBK1 | 1.05596654 |
| 51 | DMPK | 1.05216866 |
| 52 | PINK1 | 1.04654759 |
| 53 | MAP3K7 | 1.04501789 |
| 54 | SCYL2 | 1.03232128 |
| 55 | MAPK7 | 1.01722099 |
| 56 | MAPK11 | 0.96894532 |
| 57 | AKT2 | 0.96430093 |
| 58 | JAK1 | 0.96029250 |
| 59 | MYLK | 0.95997851 |
| 60 | FGFR3 | 0.94699617 |
| 61 | TAOK3 | 0.93246939 |
| 62 | PRKAA2 | 0.92926601 |
| 63 | ERBB4 | 0.91560228 |
| 64 | SGK3 | 0.88203629 |
| 65 | LRRK2 | 0.85343883 |
| 66 | LATS1 | 0.85114561 |
| 67 | GSK3A | 0.84133832 |
| 68 | PDPK1 | 0.83104255 |
| 69 | CAMK1G | 0.81007146 |
| 70 | RPS6KB1 | 0.79696257 |
| 71 | CDC42BPA | 0.79637340 |
| 72 | RPS6KA2 | 0.79178443 |
| 73 | JAK2 | 0.75733796 |
| 74 | PTK2 | 0.75600219 |
| 75 | MAP4K1 | 0.75326868 |
| 76 | MAP3K11 | 0.72545224 |
| 77 | MAP3K14 | 0.71367228 |
| 78 | WNK1 | 0.71214009 |
| 79 | IKBKE | 0.69697853 |
| 80 | STK24 | 0.69156191 |
| 81 | LMTK2 | 0.68530561 |
| 82 | MAPK12 | 0.68051097 |
| 83 | SGK2 | 0.67540246 |
| 84 | EPHA3 | 0.67532333 |
| 85 | PRKCI | 0.66886399 |
| 86 | MAP2K4 | 0.65281381 |
| 87 | MAP2K2 | 0.65135798 |
| 88 | PRKG2 | 0.63762910 |
| 89 | MAP2K6 | 0.60970674 |
| 90 | RPS6KA6 | 0.60336639 |
| 91 | MET | 0.59364628 |
| 92 | MAP3K1 | 0.59283964 |
| 93 | MAPK15 | 0.58793853 |
| 94 | PDK1 | 0.58685367 |
| 95 | ITK | 0.58210389 |
| 96 | PRKAA1 | 0.56493045 |
| 97 | ABL2 | 0.56108169 |
| 98 | RPS6KC1 | 0.53292717 |
| 99 | RPS6KL1 | 0.53292717 |
| 100 | IRAK3 | 0.53252898 |
| 101 | MELK | 0.52112869 |
| 102 | CHUK | 0.52075276 |
| 103 | MAP3K10 | 0.51946061 |
| 104 | STK38 | 0.50177606 |
| 105 | CAMK2D | 0.49196454 |
| 106 | TTN | 0.48817772 |
| 107 | MAPKAPK5 | 0.48179604 |
| 108 | CSK | 0.47620352 |
| 109 | CAMK1D | 0.47485947 |
| 110 | NME1 | 0.47385826 |
| 111 | PDGFRB | 0.47368996 |
| 112 | PIK3CG | 0.47220903 |
| 113 | KIT | 0.46497897 |
| 114 | NEK9 | 0.45391428 |
| 115 | FER | 0.45294108 |
| 116 | GRK1 | 0.45107067 |
| 117 | MST4 | 0.45016476 |
| 118 | NME2 | 0.44061240 |
| 119 | NEK1 | 0.41290055 |
| 120 | STK10 | 0.39684440 |
| 121 | MAP3K12 | 0.39180693 |
| 122 | MAPK4 | 0.36395092 |
| 123 | ZAP70 | 0.35969088 |
| 124 | JAK3 | 0.35237004 |
| 125 | ERBB2 | 0.34721854 |
| 126 | PRKD3 | 0.34323715 |
| 127 | CDK6 | 0.33250396 |
| 128 | MARK2 | 0.33004305 |
| 129 | PRKCZ | 0.32871347 |
| 130 | DYRK1B | 0.32821415 |
| 131 | PRKACG | 0.31274246 |
| 132 | PAK4 | 0.30920878 |
| 133 | TNK2 | 0.30918750 |
| 134 | CAMK2G | 0.30666824 |
| 135 | IGF1R | 0.29374274 |
| 136 | IRAK1 | 0.29273538 |
| 137 | BTK | 0.29232294 |
| 138 | PDGFRA | 0.26228049 |
| 139 | MAP3K2 | 0.25295024 |
| 140 | PIK3CA | 0.25030808 |
| 141 | CSF1R | 0.23910870 |
| 142 | DAPK2 | 0.23490270 |
| 143 | PRKCQ | 0.23219817 |
| 144 | MTOR | 0.23168113 |
| 145 | NLK | 0.22784019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35456189 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.10929528 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96932134 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.88608027 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88298053 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75807389 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.70249866 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63774089 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.60510553 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51821283 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48536123 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.39696646 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.35637959 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31173053 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25370938 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23742724 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15936437 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12515927 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09733885 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.02665944 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.94623916 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.91864833 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.88517270 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83347965 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.79847220 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.69505557 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.66835131 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64722192 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59956448 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58795020 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58454406 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56005458 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55991508 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50828241 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48525904 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47004640 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44463458 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42240090 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30381551 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28971127 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27159164 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26671655 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.22063808 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21924548 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19219462 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18596482 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17567505 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13201597 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09197898 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08276687 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.07851450 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.05644018 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05445302 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98296343 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93855819 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.92532101 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89308908 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88039901 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86882345 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86823201 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80122209 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78392814 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73962477 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73931877 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.72213466 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72150770 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71860926 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71700126 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71356210 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69880930 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67204211 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67107795 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.66222101 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64474608 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58759010 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57972239 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57356168 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54611134 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51408284 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50440545 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50009073 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49335373 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48686302 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48044813 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47003669 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46356780 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45943574 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45027943 |
| 89 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44794224 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43165109 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42706536 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42554186 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41098274 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.39662711 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.39148023 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.38497121 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32663165 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30308488 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29276441 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28362208 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27723881 |
| 102 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27216219 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26074386 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23787684 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.23615348 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16560443 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16164435 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15926545 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.14491421 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12961154 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12913720 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12273710 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11771538 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10775138 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05654777 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1427217 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1278490 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1267292 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1256385 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1223377 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0977882 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0913911 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0412775 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | -0.0345519 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0058493 |

